Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Catalyst Pharmaceuticals, Inc. (CPRX) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
$149.39M |
|
$63.73M |
|
$14.47M |
|
$134.91M |
|
$76.16M |
|
$73.23M |
|
$11.00M |
|
$84.23M |
|
$84.23M |
|
$63.73M |
|
$63.73M |
|
$63.73M |
|
$63.73M |
|
$73.23M |
|
$83.00M |
|
122.25M |
|
126.90M |
|
$0.52 |
|
$0.50 |
|
| Balance Sheet Financials | |
$940.39M |
|
$0.99M |
|
$207.22M |
|
$1.15B |
|
$132.40M |
|
-- |
|
$2.52M |
|
$134.91M |
|
$1.01B |
|
$890.73M |
|
$1.01B |
|
122.18M |
|
| Cash Flow Statement Financials | |
$59.59M |
|
$-0.03M |
|
$-12.87M |
|
$709.17M |
|
$755.86M |
|
$46.69M |
|
$6.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.10 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
90.31% |
|
49.02% |
|
49.02% |
|
-- |
|
56.38% |
|
42.66% |
|
$59.56M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.41 |
|
1.14 |
|
78.82 |
|
6.29% |
|
7.16% |
|
5.55% |
|
6.29% |
|
$8.29 |
|
$0.47 |
|
$0.47 |
|